Qiuxiang Ou

Director, Oncology Translational Research @ Geneseeq

ztvv20wt.kf@937y4w91.jk8 Sign up to see email

Known information

Co-published a study with Princess Margaret Cancer Centre on using ctDNA as a prognostic biomarker for immunotherapy
Investigated the use of ctDNA levels as predictors of treatment benefit in phase I/II immunotherapy trials
Authored research published in the JCO Precision Oncology journal

About Geneseeq

Geneseeq is a genomic testing company specializing in precision oncology, headquartered in Toronto and Nanjing, serving over 8,000 oncologists with a variety of genomic tests and supporting numerous translational research projects.

Report inaccurate information

People similar to Qiuxiang Ou

Xue Wu

Chief Executive Officer (Canada) @ Geneseeq

Hua Bao

Vice President, Research & Development @ Geneseeq

Jonathan Poh

Chief Technology Officer @ Lucence Health

Jonathan Poh is the Chief Technology Officer and a co-author of multiple publications on cancer detection and liquid biopsy technologies.